Ribon Therapeutics
Latest round
- Series B
Last raised
- Jul 2021
Total raised
- $51M
Investors
- 14
About Ribon Therapeutics
Founded in 2015 and headquartered in Cambridge, US, Ribon Therapeutics, Inc. is dedicated to advancing therapeutic solutions in oncology.26 mn.Ribon Therapeutics develops a range of small molecule therapies aimed at treating various types of cancer. Their focus is on innovative solutions that specifically target the mechanisms of disease, enhancing the efficacy of cancer treatments and improving patient outcomes., Ribon Therapeutics plans to utilize this capital to further develop its first small molecule programs in oncology. The company is focused on expanding its research and development initiatives, striving to enhance its product pipeline and potentially launch new therapies in the coming years. Ribon Therapeutics is also exploring opportunities to enter new markets and geographic regions to broaden its reach in the biotech industry.
Who invested in Ribon Therapeutics
14 investors across 2 rounds
See all investors in Ribon Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ribon Therapeutics
Who invested in Ribon Therapeutics?
Ribon Therapeutics has 14 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ribon Therapeutics raised?
Ribon Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ribon Therapeutics last raise money?
Ribon Therapeutics's most recent round on record is a Series B, in Jul 2021.
What does Ribon Therapeutics do?
Founded in 2015 and headquartered in Cambridge, US, Ribon Therapeutics, Inc.
Where is Ribon Therapeutics headquartered?
Ribon Therapeutics is headquartered in Cambridge, US.
Which VCs invest in companies like Ribon Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ribon Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Ribon Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.